Video29 April 2024 The impact of an AI-enabled consent process Exploring how early engagement with trial participants through an AI enabled chatbot can enhance both comprehension and satisfaction. Learn more
Video Spring updates & a highlight on ePRO in Oncology Listen in as Derk gives an update on what is happening at Castor this March, as well as recaps the recent ePRO in oncology webinar. Learn more
Video Kicking-off 2024: A year of optimism & opportunity Listen in for Derk’s take on the JPM conference, and what to expect from a first quarter filled with optimism and opportunities at Castor. Learn more
Video19 December 2023 2023: Castor Year in Review As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric trials accessible worldwide. Learn more
Video24 November 2023 The AI Hype and Reality: Key Highlights from CNS Summit 2023 At this year’s CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more to hear on-site updates from Derk! Learn more
Video31 October 2023 What to expect at the CNS Summit Live AI Demo As the world works towards a future of AI-assisted solutions, we believe that everyone who is involved in the process of clinical trials should have access to valuable tools and be able to leverage these emerging technologies. Learn more
Video28 September 2023 Understand Barriers to eConsent Adoption from Site and Sponsor Perspectives Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges. Learn more
Video24 August 2023 Harnessing the power of Patient-centric Technologies Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges. Learn more
Video19 June 2023 AI & Air Hockey – What to expect at DIA? Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel discussion and what to expect at DIA. Learn more
Video12 May 2023 Unlocking the potential of GPT-generated eConsent for IRB approval As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these trials more and more, researchers have come to appreciate the significance of establishing uniform approaches for evaluating and analyzing real-world data (RWD). Learn more